Species differences in distribution and prediction of human V(ss) from preclinical data.

作者: Loren M. Berry , Chao Li , Zhiyang Zhao

DOI: 10.1124/DMD.111.040766

关键词:

摘要: Prediction of human volume distribution at steady state (V(ss)) before first administration a new drug candidate to humans has become an important part the development process. This study examines assumptions behind interspecies scaling techniques used predict V(ss) from preclinical data, namely equivalency V(ss,u) and/or f(ut) across species. In addition, several are evaluated side by using set 67 reference compounds where observed rats, dogs, monkeys, and were compiled literature plasma protein binding was determined species ultracentrifugation technique. Species similarity in or does not appear be norm among humans. Despite this, monkeys is useful can provide reasonably accurate predictions V(ss), although some approaches better than others. For example, performance common average three superior allometric techniques. considering data species, approach, any single Although mechanistic tissue composition equations available Simcyp population-based pharmacokinetic simulator did necessarily most predictions, likely need refinement, they still best opportunity for understanding prediction V(ss).

参考文章(45)
R G Cooper, A Hayes, STUDIES ON THE ABSORPTION, DISTRIBUTION AND EXCRETION OF PROPRANOLOL IN RAT, DOG AND MONKEY Journal of Pharmacology and Experimental Therapeutics. ,vol. 176, pp. 302- 311 ,(1971)
M. Depré, D. J. Margolskee, A. Van Hecken, J. S. Y. Hsieh, A. Buntinx, P. J. De Schepper, J. D. Rogers, Dose-dependent kinetics of the enantiomers of MK-571, and LTD4-receptor antagonist. European Journal of Clinical Pharmacology. ,vol. 43, pp. 431- 433 ,(1992) , 10.1007/BF02220622
Yuping Gong, Zhiyang Zhao, Donavon J. McConn, Beth Beaudet, Melanie Tallman, Jason D. Speake, Diane M. Ignar, Jeffrey P. Krise, Lysosomes Contribute to Anomalous Pharmacokinetic Behavior of Melanocortin-4 Receptor Agonists Pharmaceutical Research. ,vol. 24, pp. 1138- 1144 ,(2007) , 10.1007/S11095-007-9239-Y
S. R. Howell, D. R. Hicks, J. A. Scatina, S. F. Sisenwine, Pharmacokinetics of venlafaxine and O-desmethylvenlafaxine in laboratory animals Xenobiotica. ,vol. 24, pp. 315- 327 ,(1994) , 10.3109/00498259409045895
Masanori Kuroha, Akinori Azumano, Yoji Kuze, Minoru Shimoda, Eiichi Kokue, Effect of Multiple Dosing of Ketoconazole on Pharmacokinetics of Midazolam, a Cytochrome P-450 3A Substrate in Beagle Dogs Drug Metabolism and Disposition. ,vol. 30, pp. 63- 68 ,(2002) , 10.1124/DMD.30.1.63
L.N. Sansom, J. Necciari, J.F. Thiercelin, Human pharmacokinetics of tiludronate Bone. ,vol. 17, ,(1995) , 10.1016/8756-3282(95)00259-6
Leonid M. Berezhkovskiy, Volume of Distribution at Steady State for a Linear Pharmacokinetic System with Peripheral Elimination Journal of Pharmaceutical Sciences. ,vol. 93, pp. 1628- 1640 ,(2004) , 10.1002/JPS.20073
Anita Grover, Leslie Z. Benet, Effects of drug transporters on volume of distribution Aaps Journal. ,vol. 11, pp. 250- 261 ,(2009) , 10.1208/S12248-009-9102-7
Xiaofan Sui, Jin Sun, Haiyan Li, Yang Pan, Yongjun Wang, Zhonggui He, None, Contribution of Molecular Properties to Extrapolation of the Volume of Distribution in Human from Preclinical Animal Species Data Biopharmaceutics & Drug Disposition. ,vol. 31, pp. 464- 475 ,(2010) , 10.1002/BDD.727
M. Ishizuka, S. Nagai, K. Q. Sakamoto, S. Fujita, Plasma pharmacokinetics and CYP3A12-dependent metabolism of c-kit inhibitor imatinib in dogs Xenobiotica. ,vol. 37, pp. 503- 513 ,(2007) , 10.1080/00498250600962849